• Savient Pharmaceuticals, Inc. (SVNT) Reveals KRYSTEXXA Phase III Data Improves HRQOL in RCG Patients More...

• Argos Therapeutics, Inc. Receives FDA Approval of Special Protocol Assessment for AGS-003 Phase 3 Trial More...

• Amicus Therapeutics, Inc. (FOLD) Announces Publication of BLISS Quantitative Histology Method in Archives of Pathology & Laboratory Medicine More...

• ImmunoCellular Therapeutics, Ltd Provides Update on Phase II Clinical Trial of ICT-107 for Treatment of Glioblastoma More...

• FDA Approves Cornerstone Therapeutics Inc.' ANDA for Generic Tussionex® Pennkinetic® Product More...

• NuPathe Inc. (PATH) Updates Migraine Patch NDA Resubmission Timing More...

• Janssen Research & Development Submits New Drug Application to FDA for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline (TMC207) More...

• Rexahn Pharmaceuticals, Inc. Submits an Investigational New Drug Application to the FDA for First-in-Class p68 Helicase Inhibitor, RX-5902 More...

• Caffeinated Coffee Could Cut Skin Cancer Risk, Brigham and Women's Hospital and Harvard Medical School Study More...

• Skipping Breakfast Can Lead to Unhealthy Habits All Day Long, Institute of Food Technologist Reveals More...
• Hot Flashes Don't Signal Poor Heart Health for Most Women, Northwestern University Feinberg School of Medicine Study More...

• Spanking Kids Leads to Adult Mental Illnesses, University of Manitoba Study More...

• Sleep Deprivation and Stress Both Activate Immune System, Eramus MC University Medical Center Rotterdam Study More...

• Amarin Corporation PLC (AMRN) Announces Notice of Allowance for Additional U.S. Patent Covering AMR101 More...

• AVANIR Pharmaceuticals (AVNR) Announces Notice of Allowance of U.S. Patent Application Covering NUEDEXTA More...

• CytRx Corporation (CYTR) Announces Issuance of European Patent Covering INNO-206 Linker Technology More...

• FDA Issues Further Guidance About K-V Pharmaceutical Company (KV-A)'s Makena More...

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Release: Cold-EEZE® Announces Launch of NEW Cold-EEZE® Cold Remedy Daytime/Nighttime QuickMelts® and Achieves Nationwide Product Distribution More...

• Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Ibandronate Sodium Tablets More...